1. Home
  2. Directory
  3. Connecticut
  4. Westport
  5. Psychiatry Neurology
  6. NPI Profile
  7. Prescriptions 1801932207

DR. RENATA WEISSBERG MD
Prescription History 1801932207
Psychiatry & Neurology - Psychiatry in Westport, CT

NPI Status: Active since January 30, 2007

Contact Information

225 MAIN ST
L-1
WESTPORT, CT
ZIP 06880
Phone: (203) 291-4043
Fax: (203) 373-9355

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. RENATA WEISSBERG MD, an active Psychiatry specialist practicing in Westport, CT. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 39 documented patient claims. Among these therapy options, the most frequently utilized medication is Fluoxetine Hcl, which accounts for 16 claims alone.

Medication Index

B
F
L
No matching medications currently found on file.

Bupropion Hcl Sr

Generic Formulation: Bupropion HclSpecialty: Psychiatry & Neurology
Provider Metrics Summary
Total Claims 12
30-Day Fills 22.0
Days Supply 660
CT State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills38.3
Peer Average Days Supply1,124
Conservative Utilization

This provider writes prescriptions for this formulation 45.5% less frequently than the standard regional baseline metric for practitioners inside CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $424.30 across this reporting matrix range.

Provider Avg Cost Per Claim

$35.36

State Avg Cost Per Claim

$32.94

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Bupropion is used to treat depression. It can improve your mood and feelings of well-being. It may work by helping to restore the balance of certain natural chemicals (neurotransmitters) in your brain.

Fluoxetine Hcl

Generic Formulation: Fluoxetine HclSpecialty: Psychiatry & Neurology
Provider Metrics Summary
Total Claims 16
30-Day Fills 28.0
Days Supply 840
CT State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills66.7
Peer Average Days Supply1,970
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 54.3% less volume than the regional standard for practitioners inside CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $317.27 across this reporting matrix range.

Provider Avg Cost Per Claim

$19.83

State Avg Cost Per Claim

$17.15

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.

Therapeutic Applications

This long-acting form of fluoxetine is used to treat depression in people who have been successfully treated with the form of fluoxetine that is taken daily. Fluoxetine is a selective serotonin reuptake inhibitor (SSRI). SSRIs work by helping to restore the balance of certain natural substances in the brain (neurotransmitters such as serotonin). Fluoxetine may decrease anxiety, improve your mood, sleep, appetite, and energy level and may help restore your interest in daily living.

Lamotrigine

Generic Formulation: LamotrigineSpecialty: Psychiatry & Neurology
Provider Metrics Summary
Total Claims 11
30-Day Fills 27.9
Days Supply 837
CT State Average Benchmarks
Peer Average Claims47.0
Peer Average 30-Day Fills74.0
Peer Average Days Supply2,156
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 76.6% less volume than the regional standard for practitioners inside CT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $361.94 across this reporting matrix range.

Provider Avg Cost Per Claim

$32.90

State Avg Cost Per Claim

$16.61

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A phenyltriazine compound, sodium and calcium channel blocker that is used for the treatment of SEIZURES and BIPOLAR DISORDER.

Therapeutic Applications

Lamotrigine is used alone or with other medications to prevent and control seizures. It may also be used to help prevent the extreme mood swings of bipolar disorder in adults. Lamotrigine is known as an anticonvulsant or antiepileptic drug. It is thought to work by restoring the balance of certain natural substances in the brain. This drug is not approved for use in children younger than 2 years due to an increased risk of side effects (such as infections).

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. RENATA WEISSBERG MD provides transparency into local medical care patterns within Westport, CT.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Psychiatry** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.